Crossmark

Dual Targeted Therapy with Baricitinib and Anifrolumab in Infantile Spondyloenchondrodysplasia with Immune Dysregulation

Published Online: 2025-11-08

Published Print: 2025-12

Authors

Pandurangi, Sindhu

Soucy, Nicole

Moreda, Claudia M.

Singh, Vivekanand

Wysocki, Christian A.
License Information

Text and Data Mining valid from 2025-11-08

Version of Record valid from 2025-11-08
More Information

Article History

Received: 19 March 2025

Accepted: 13 October 2025

First Online: 8 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current